Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Saby George

Showing results (21-30 of 93) with videos related to

Pageof 10
Sort By:
European Urology Focus|June 14, 2025
Biological and Clinical Insight into the Prevention and Management of Metastatic Renal Cell Carcinoma with a Sarcomatoid ComponentNicholas J Salgia, Yu Fujiwara, Bo Xu, et al.
Clinical Lung Cancer|July 16, 2008
Phase I study of flavopiridol in combination with Paclitaxel and Carboplatin in patients with non-small-cell lung cancerSaby George, Basil S Kasimis, Janet Cogswell, et al.
The Journal of Community and Supportive Oncology|March 9, 2016
A novel treatment approach prolonging survival in an uncommon metastatic primary bladder adenocarcinomaVenkata K Pokuri, Norbert Sule, Caroline Perfetto, et al.
Anticancer Research|May 13, 2015
Radiation-induced Chondrosarcoma of the Bladder. Case Report and Review of LiteratureNorbert Sule, B O Xu, Dima El Zein, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|July 8, 2015
Strategies to Circumvent Testosterone Surge and Disease Flare in Advanced Prostate Cancer: Emerging Treatment ParadigmsVenkata K Pokuri, Houman Nourkeyhani, Bodie Betsy, et al.
The Oncologist|July 30, 2021
Real-World Clinical and Economic Outcomes in Selected Immune-Related Adverse Events Among Patients with Cancer Receiving Immune Checkpoint InhibitorsYing Zheng, Ruth Kim, Ting Yu, et al.
Cancer Chemotherapy and Pharmacology|October 3, 2007
Phase I trial of PEG-interferon and recombinant IL-2 in patients with metastatic renal cell carcinomaSaby George, Thomas E Hutson, Tarek Mekhail, et al.
The Oncologist|December 8, 2020
A Randomized Phase II Study of AGS-16C3F Versus Axitinib in Previously Treated Patients with Metastatic Renal Cell CarcinomaChristian Kollmannsberger, Toni K Choueiri, Daniel Y C Heng, et al.
The Oncologist|March 3, 2023
Characterization and Management of Adverse Reactions From the CLEAR Study in Advanced Renal Cell Carcinoma Treated With Lenvatinib Plus PembrolizumabRobert Motzer, Saby George, Jaime R Merchan, et al.
Oncotarget|April 17, 2017
Selenomethionine and methyl selenocysteine: multiple-dose pharmacokinetics in selenium-replete menJames R Marshall, Raymond F Burk, Rochelle Payne Ondracek, et al.
Pageof 10

Showing results (21-30 of 93) with videos related to

Sort By:
Pageof 10
European Urology Focus|June 14, 2025
Biological and Clinical Insight into the Prevention and Management of Metastatic Renal Cell Carcinoma with a Sarcomatoid ComponentNicholas J Salgia, Yu Fujiwara, Bo Xu, et al.
Clinical Lung Cancer|July 16, 2008
Phase I study of flavopiridol in combination with Paclitaxel and Carboplatin in patients with non-small-cell lung cancerSaby George, Basil S Kasimis, Janet Cogswell, et al.
The Journal of Community and Supportive Oncology|March 9, 2016
A novel treatment approach prolonging survival in an uncommon metastatic primary bladder adenocarcinomaVenkata K Pokuri, Norbert Sule, Caroline Perfetto, et al.
Anticancer Research|May 13, 2015
Radiation-induced Chondrosarcoma of the Bladder. Case Report and Review of LiteratureNorbert Sule, B O Xu, Dima El Zein, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|July 8, 2015
Strategies to Circumvent Testosterone Surge and Disease Flare in Advanced Prostate Cancer: Emerging Treatment ParadigmsVenkata K Pokuri, Houman Nourkeyhani, Bodie Betsy, et al.
The Oncologist|July 30, 2021
Real-World Clinical and Economic Outcomes in Selected Immune-Related Adverse Events Among Patients with Cancer Receiving Immune Checkpoint InhibitorsYing Zheng, Ruth Kim, Ting Yu, et al.
Cancer Chemotherapy and Pharmacology|October 3, 2007
Phase I trial of PEG-interferon and recombinant IL-2 in patients with metastatic renal cell carcinomaSaby George, Thomas E Hutson, Tarek Mekhail, et al.
The Oncologist|December 8, 2020
A Randomized Phase II Study of AGS-16C3F Versus Axitinib in Previously Treated Patients with Metastatic Renal Cell CarcinomaChristian Kollmannsberger, Toni K Choueiri, Daniel Y C Heng, et al.
The Oncologist|March 3, 2023
Characterization and Management of Adverse Reactions From the CLEAR Study in Advanced Renal Cell Carcinoma Treated With Lenvatinib Plus PembrolizumabRobert Motzer, Saby George, Jaime R Merchan, et al.
Oncotarget|April 17, 2017
Selenomethionine and methyl selenocysteine: multiple-dose pharmacokinetics in selenium-replete menJames R Marshall, Raymond F Burk, Rochelle Payne Ondracek, et al.
Pageof 10